BMY
58
5
BF.B
31
3
DRI
48
3
ROK
47
-8
EQR
59
5
PH
73
3
GLW
46
4
UNP
45
6
MOS
46
4
GOOG
53
-12
AVB
64
4
RRC
59
-4
ABT
62
5
WM
76
3
STI
31
-16
AIV
70
2
JPM
67
4
BRK.B
42
2
HBAN
56
2
AMGN
38
-6
BMY
58
5
BF.B
31
3
DRI
48
3
ROK
47
-8
EQR
59
5
PH
73
3
GLW
46
4
UNP
45
6
MOS
46
4
GOOG
53
-12
AVB
64
4
RRC
59
-4
ABT
62
5
WM
76
3
STI
31
-16
AIV
70
2
JPM
67
4
BRK.B
42
2
HBAN
56
2
AMGN
38
-6
Financhill
Back

Pieris Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
43

PIRS
Pieris Pharmaceuticals

Last Price:
16.64
Seasonality Move:
14.9%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
43
Pieris Pharmaceuticals (PIRS) is a Sell

Is Pieris Pharmaceuticals a Buy, Sell or Hold?

  • The current Pieris Pharmaceuticals [PIRS] share price is $15.93. The Score for PIRS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • PIRS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PIRS Stock Price Chart

What is Pieris Pharmaceuticals's stock price today?

  • The Pieris Pharmaceuticals share price today is $15.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PIRS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

PIRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 43.29 Sell
Chaikin Money Flow: 8327 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.01 - 17.05) Sell
Bollinger Bands (100): (12.17 - 18.69) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: 23717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.27 - 1.45) Sell

PIRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.88 Buy
20-day SMA: 16.45 Sell
50-day SMA: 16.52 Sell
200-day SMA: 13.81 Buy
8-day EMA: 15.95 Sell
20-day EMA: 16.25 Sell
50-day EMA: 16.27 Sell
200-day EMA: 17.42 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.66 Buy
200-day SMA: 2.35 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.62 Sell

Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Pieris Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):